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ABSTRACT
Carcinogenesis is determined based on both cell
proliferation and death rates. Recent studies dem-
onstrate that heat shock proteins (HSPs) regulate
apoptosis. HLJ1, a member of the DnaJ-like Hsp40
family, is a newly identified tumor suppressor
protein closely related to relapse and survival in
non-small cell lung cancer (NSCLC) patients.
However, its role in apoptosis is currently
unknown. In this study, NSCLC cell lines displaying
varying HLJ1 expression levels were subjected to
ultraviolet (UV) irradiation, followed by flow
cytometry. Interestingly, the percentages of apop-
totic cells in the seven cell lines examined were
positively correlated with HLJ1 expression.
Enforcing expression of HLJ1 in low-HLJ1 express-
ing highly invasive cells promoted UV-induced
apoptosis through enhancing JNK and caspase-3
activation in NSCLC. Additionally, UV irradiation
led to reduced levels of HLJ1 predominantly in
apoptotic cells. The pan-caspase inhibitor, zVAD-
fmk and caspase-3-specific inhibitor, DEVD-fmk,
prevented UV-induced degradation of HLJ1 by the
late stage of apoptosis. Further experiments
revealed a non-typical caspase-3 cleavage site
(MEID) at amino acid 125–128 of HLJ1. Our results
collectively suggest that HLJ1 is a novel substrate of
caspase-3 during the UV-induced apoptotic
process.
INTRODUCTION
The past few decades have seen a dramatic increase in the
number of publications on apoptosis. Apoptosis is an es-
sential process during normal embryonic development,
adult homeostasis and regulation of the immune system
(1). Various cellular stress factors, including anti-cancer
drugs, ionizing radiation and ultraviolet (UV) light,
induce apoptosis and activation of signaling pathways
(2–4). UV irradiation has multiple eﬀects on cells,
including DNA damage, and triggers expression of genes
involved in DNA repair and apoptosis (5).
Heat shock proteins (HSPs) were initially identiﬁed in
1962 (6) as molecular chaperones induced by various
stress conditions, including heat shock, exposure to radi-
ation, heavy metals, ethanol, amino acid analogs, sodium
arsenite and oxidative stress (7). HSPs are classiﬁed into
six main groups according to molecular weight: Hsp100,
Hsp90, Hsp70, Hsp60, Hsp40 and small HSP. Further
studies in recent years indicate that HSPs regulate apop-
tosis, although the results to date are inconsistent. Hsp27
and Hsp70 are antiapoptotic proteins (8,9), whereas
Hsp60 and Hsp10 promote the proteolytic maturation of
caspase-3 (10). Moreover, Hsp105a prevents stress-
induced apoptosis in neuronal PC12 cells (11), but
enhances hydrogen peroxide-induced apoptosis in a
mouse embryonic cell line (12). To date, Hsp40 has been
characterized simply as a co-chaperone involved in the
regulation of Hsp70 chaperone activity, but it is currently
unclear whether this protein family is independently
involved in the regulation of apoptosis (13).
Additionally, the Hsp40 (DnaJ)–Hsp70 chaperone pair
prevents against NO-induced apoptosis through
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mitochondria (14). However, it remains to be established
whether HSPs are substrates of caspases.
Increasing attention is focused on DnaJ-like HSPs in
tumor suppression analyses (15). HLJ1 is a DnaJ-like
HSP belonging to the Hsp 40 family (16). In a previous
study, we characterized HLJ1 as a novel tumor suppressor
that inhibits cancer cell-cycle progression, proliferation,
invasion and tumorigenesis, and is signiﬁcantly correlated
with prognosis in non-small cell lung carcinoma (NSCLC)
patients (17). Moreover, HLJ1 is synergistically activated
by the enhancer, AP-1, and promoter, YY1, through
DNA bending (18,19). The mechanism of action of
HLJ1 is of signiﬁcant interest in the context of tumor sup-
pression, but is yet to be fully explored. The objective of
this study was to investigate the role of HLJ1 in apoptosis
of lung cancer cells exposed to UV stress.
MATERIALS AND METHODS
Cell culture
Seven human NSCLC cell lines, CL1-0, CL1-1, CL1-5,
CL1-5–F4, with diﬀerent invasive capacities (20),
NCI-H358 (ATCC CRL-5807), NCI-H1437 (ATCC
CRL-5872), A549 (ATCC CCL-185) and one human
cervical carcinoma cell line, HeLa, were maintained at
37 C in a humidiﬁed atmosphere of 5% CO2. Cells were
cultured in RPMI 1640 (GIBCO BRL, Grand Island, NY,
USA) with 10% heat-inactivated fetal bovine serum
(GIBCO BRL), and 1% penicillin and streptomycin
(GIBCO BRL).
Construct preparation and transfection
To generate HLJ1 constructs, full-length HLJ1 cDNA was
inserted into pcDNA3 (Invitrogen, Carlsbad, CA, USA),
pEF6-V5/His (Invitrogen) and pQE-30 (Qiagen, Hilden,
Germany), as described previously (17). For caspase-3
construct, full-length caspase-3 cDNA was inserted into
pGEX-4T-1 vector containing GST tag (Amersham
Pharmacia Biotech, Piscataway, NJ, USA). GST-tagged
caspase-3 (C163S) (21), His-tagged HLJ1 (D128A) and
V5-tagged HLJ1 (D128A) mutant constructs were
produced with the QuikChange site-directed mutagenesis
kit (Stratagene). All constructs were conﬁrmed by DNA
sequencing.
CL1-5 cells expressing low levels of HLJ1 were seeded in
6cm dishes at 5 10
5 cells/dish and transfected with
pcDNA3-HLJ1, pcDNA3 empty vector, pEF6-V5/
His-HLJ1-D128A or pEF6-V5/His using Lipofectamine
Reagent (Invitrogen), according to the manufacturer’s
protocol. After culturing in medium containing 400mg/
ml of geneticin (G418; GIBCO BRL) or 5mg/ml of
Blastidine (Invitrogen) for 2–3 weeks, single and mixed
clones were isolated. For silencing HLJ1 expression,
small-interfering RNA (siRNA) transient transfection
was performed as previously described (17). The
HLJ1-speciﬁc siRNA sequence and scrambled siRNA
sequence were as follows, respectively, AACCCGGAAT
GAGGAGAAGAA and GGACAATGAACACGAGGA
AGA. The CL1-0 and HLJ1-2 were transfected with
HLJ1-speciﬁc or scrambled siRNA using the RNAiFect
Transfection Reagent (Qiagen). After culturing in the
medium for 36h, the cells were exposed to UV irradiation.
UV irradiation and apoptosis assay
Cells were seeded in 10cm dishes at a concentration of
8 10
5 cells/dish. After a 24h pre-incubation period,
cells were exposed to 10, 20 or 50J/m
2 of UV (254nm)
(BIO-LINK BLX-254, Vilber Lourmat, France), and
allowed to recover for 3, 6, 9, 12, 24 or 48h, depending
on the experimental design. Aliquots of cells were pre-
treated with 10mg/ml cycloheximide (CHX; Calbiochem,
CA, USA.), 20mM zVAD-fmk (a broad caspase inhibitor,
BD Biosciences, San Diego, CA, USA) or 30mM
DEVD-fmk (a caspase-3 speciﬁc inhibitor, BD
Biosciences), and exposed to UV irradiation.
X-irradiation and drug treatment
X-irradiation was followed essentially as described previ-
ously (22). Cells were seeded in 75T ﬂask at a concentra-
tion of 5 10
5 cells/ﬂask. After pre-incubation period,
cells were irradiated using 6 MV X-rays produced by a
linear accelerator (SLi Precise 25001, ELEKTA) and
allowed to recover for 72h. X-ray doses ranged from 10
to 20Gy. Paclitaxel (Bristol-Myers Squibb Co, Wal-
lingford, CT) and staurosporine (Sigma, St. Louis, MO,
USA) were prepared in sterile dimethylsulfoxid (DMSO;
99.8% pure; Sigma). The ﬁnal concentration of DMSO in
drug or mock control was <0.1%.
Western blot analysis
Western blot analysis was performed essentially as
described previously (17). Cells were rinsed with PBS,
and lysed in RIPA buﬀer (1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS, 50mM Tris–HCl and
pH 7.5) containing protease inhibitors. Aliquots (30mg
proteins) of cell extracts were separated by SDS–PAGE,
and transferred to PVDF membranes (Immobilon-P
membrane; Millipore, Bedford, MA). The membranes
were blocked with 5% skim milk in PBS containing
0.1% Tween-20 (PBST), followed by primary antibody
in PBST/5% skim milk. The primary antibodies used for
western blot analyses included monoclonal mouse
anti-HLJ1 (made in-house), polyclonal goat anti-Hsc70
antibody (sc-1059, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), monoclonal mouse anti-Hsp70
antibody (sc-24, Santa Cruz Biotechnology), polyclonal
rabbit anti-SAPK/JNK antibody (Cat. 9252, Cell
Signaling Technology, Beverly, MA, USA), monoclonal
mouse anti-phospho-SAPK/JNK (Thr183/Tyr185)
antibody (Cat. 9255, Cell Signaling Technology), poly-
clonal rabbit anti-caspase-3 antibody (Cat. AB1899,
Millipore), monoclonal mouse anti-caspase-9 antibody
(Cat. 551246, BD Biosciences), polyclonal rabbit anti-
PARP antibody (Cat. 5242, Cell Signaling Technology),
and monoclonal mouse anti-b-tubulin (Cat. 05-661,
Millipore) used as a loading control. Membranes were
washed three times with PBST, followed by incubation
with horseradish peroxidase-conjugated secondary
antibody (Santa Cruz Biotechnology) in PBST/5% skim
Nucleic Acids Research, 2010,Vol.38, No. 18 6149milk. Antibody–antigen complexes were detected using the
Enhanced Chemiluminescence System (Amersham). All
experiments were performed in triplicate.
Quantitative reverse transcription–PCR (RT–PCR)
The HLJ1 mRNA level was detected with SYBR Green
real-time RT–PCR on an ABI Prism 7300 sequence detec-
tion system (Applied Biosystems). The TATA box-binding
protein (TBP) was used as an internal control. The follow-
ing primers were used: HLJ1 forward, 50-CCAGCAGAC
ATTGTTTTTATCATT-30, HLJ1 reverse, 50-CCATCCA
GTGTTGGTACATTAATT-30; TBP forward, 50-CACG
AACCACGGGACTGATT-30 and TBP reverse, 50-TTT
TCTTGCTGCCAGTCTGGAC-30. All experiments were
performed in triplicate. The relative expression level of
HLJ1, compared with that of TBP, was deﬁned as
 CT= (CTHLJ1 CTTBP), whereas the relative expres-
sion ratio of HLJ1 between diﬀerent treatments was
calculated as  CT= (CTUV CTCTL). The




A ﬂow cytometer was employed to determine the percent-
age of the sub-G1 cell population, indicative of
UV-induced apoptosis. In brief, tested cells were seeded
at a density of 5 10
5 cells/6cm dish in medium with 10%
FBS for 24h, and exposed to 10, 20 or 50J/m
2 of UV.
After recovery for 6, 12, 24 or 48h, each sample was
washed with ice-cold PBS, harvested and ﬁxed in 70%
(v/v) ethanol for 2h at  20 C. Cells were treated with
RNase A, and stained with 25mg/ml propidium iodide.
Samples were analyzed using a Cytomics
TM FC500 ﬂow
cytometer (Beckman Coulter), according to the manufac-
turer’s protocol. Cytometric data were analyzed with
WinMDI 2.8 software. A minimum of 10000 events
were examined. Three independent experiments were
performed.
In vitro cleavage of HLJ1 by recombinant caspase-3
Recombinant His-tagged HLJ1 was incubated with re-
combinant active caspase-3 (BD Biosciences) at 37 C for
2h in 25ml reaction buﬀer (50mM HEPES, 0.1M NaCl,
10% glycerol, pH7.5 and 10mM DTT). The reaction was
terminated by the addition of sample buﬀer, and analyzed
by SDS–PAGE, followed by Coomassie blue staining.
Proteins were identiﬁed with a Mass Spectrometer
(MALDI-TOF, ABI Voyager-DE PRO, supported by
Biotechnology Center, National Chung Hsing
University) and N-terminal sequencing (ABI Procise
492, supported by Technology Commons, College of
Life Science, National Taiwan University). In an inhib-
ition experiment, recombinant caspase-3 was
pre-incubated with 1mM DEVD-fmk at room temperature
for 15min in the reaction buﬀer, and the reaction is
initiated by the addition of recombinant His-tagged HLJ1.
Statistical analysis
Results are presented as mean±SD. All experiments were
performed in triplicate, and analyzed for signiﬁcant diﬀer-
ences using analysis of variance (ANOVA). P<0.05 was
considered statistically signiﬁcant.
RESULTS
Relationship between HLJ1 expression and UV-induced
apoptosis in NSCLC cell lines
The endogenous HLJ1 protein levels in a variety of
NSCLC cell lines are depicted in Figure 1A. Expression
levels of HLJ1 were further digitized and normalized with
internal control b-tubulin (Figure 1B). Highest HLJ1 ex-
pression was observed in CL1-0 and CL1-1, moderate ex-
pression in A549, H358 and H1437, and lowest expression
in CL1-5 and CL1-5F4 cell lines. Interestingly, after UV
irradiation at an intensity of 10J/m
2 and cell recovery for
24h, the apoptotic cell percentage was consistent with
HLJ1 expression patterns (Figure 1C). The data show
that the sub-G1 percentage of CL1-0 irradiated with UV
increases 15.9-fold (from 1.42±0.39% to 22.56±
1.08%). In contrast to the CL1-0 cell line displaying
high HLJ1 protein expression, the sub-G1 percentage of
CL1-5 cells expressing low HLJ1 levels barely increased
(from 1.81±0.97% to 2.36±0.79%).
Augmentation of UV-induced apoptosis in
HLJ1-expressing CL1-5 cells
To further establish the eﬀects of HLJ1 on UV
irradiation-induced apoptosis, HLJ1-expressing or empty
vector was introduced into CL1-5 cells expressing low
levels of HLJ1. The morphological properties of CL1-5
cells transfected with HLJ1 (HLJ1-1 and HLJ1-2) were
altered, compared with those of mock transfectants,
mock-1 and mock-2 (Figure 2A). Upon HLJ1 transfec-
tion, CL1-5 cells displayed a less elongated cell shape.
Cells lost their ﬁbroblast-like appearance and assumed
epithelial cell morphology, without a bipolar or spindle
shape, and ﬂattened onto plates, similar to CL1-0 cells.
Next, we examined the eﬀects of HLJ1 overexpression
on UV-induced apoptosis in the CL1-5 cell line. Clones
stably expressing HLJ1 were identiﬁed by western blot,
and subjected to the apoptotic assay (Figure 2B). Cell
lines, including CL1-5, mock controls and HLJ1 transfect-
ants, were exposed to 50J/m
2 of UV, and allowed to
recover for 6, 12 or 48h before analysis of the percentage
of apoptosis with ﬂow cytometry. Induction of HLJ1 ex-
pression led to a signiﬁcant elevation in the apoptotic cell
percentage by  2–3-fold, compared to that of cells con-
taining the empty vector (Figure 2C). On the contrary,
silencing HLJ1 with HLJ1-speciﬁc siRNA would cause a
marked decrease of apoptotic cell percentage, compared
to the scrambled control (Figure 2D).
Induction of HLJ1 expression leads to enhanced
activation of JNK and caspase-3 after UV irradiation
JNK pathways are activated by UV stress, resulting in the
caspase cascade and initiation of apoptotic processes, and
6150 Nucleic Acids Research, 2010,Vol.38, No. 18are implicated as key regulators of stress-induced apop-
tosis in a variety of cell types (4,23). To determine whether
HLJ1 is involved in JNK signaling pathways, we
examined the phosphorylation of JNK in CL1-5 cells
exposed to UV stress. The results illustrated in
Figure 3A provide evidence that UV stress induces
marked JNK activation within 15min in HLJ1 transfect-
ants, compared with mock control cells. It appears that
enforced expression of HLJ1 enhances the UV
stress-induced activation of JNK. Accordingly, we
further assayed caspase-3 and -9 activities in
UV-exposed cells. Both caspase activities remained un-
changed for 24h in mock control cells, but increased
markedly in HLJ1-transfected cell clones within 12h
(Figure 3B). PARP is an important substrate of
caspase-3. Interestingly, cleavage of PARP under UV
stress conditions was markedly increased in HLJ1 trans-
fectants, compared to mock controls (Figure 3B), consist-
ent with the increased caspase-3 activity.
Reduction of HLJ1 in UV-exposed cells
To determine the dynamic relationship between HLJ1 and
cell death, dose-eﬀect and time-course responses of HLJ1
expression and apoptosis to UV exposure were analyzed.
CL1-0 cells were exposed to: (i) UV at intensities of 10, 20
or 50J/m
2, followed by recovery for 6h; and (ii) 10J/m
2 of
UV and recovery over a period of 3–24h. Western blot
analyses disclose a dose-dependent decrease in the HLJ1
level, compared with non-treated control, at 10, 20 or 50J/
m
2 UV exposure (Figure 4A). However, Hsc70 and Hsp70
levels remained unaﬀected under all assay conditions. The
amounts of HLJ1 in CL1-0 recovered at 3, 6, 9, 12 and
24h after UV exposure were reduced to 1-, 0.75-, 0.48-,
0.35- and 0.35-fold, compared with control, respectively
(Figure 4B). Again, no alterations in Hsc70 were observed
at all assay time-points. The decrease in HLJ1 was
accompanied by increased caspase-3 activity and
cleavage of PARP. In addition, decreased HLJ1 levels
were observed in transfectants derived from CL1-5,
HLJ1-1 and HLJ1-2, following irradiation with 50J/m
2
UV and recovery for 12h (Figure 4C). This result is
similar to that obtained in Figure 2D.
HLJ1 is cleaved by caspase in apoptotic cells
To establish the mechanisms underlying HLJ1 reduction,
further experiments were performed with regard to inhib-
ition of transcription and acceleration of protein degrad-
ation. Prior to exposure to UV, CL1-0 cells were
pre-incubated with CHX to inhibit de novo protein syn-
thesis. Western blot analyses showed that UV exposure led
to a decrease in the HLJ1 level by 28.7%, compared with
non-treated control. However, upon pre-treatment with
CHX, a reduction of 70.3% was observed (Figure 5A,
left). Furthermore, the addition of CHX to cell culture
did not aﬀect the reduction level of HLJ1 mRNA,
indicating that degradation occurs at the protein level
(Figure 5A, right).
To determine the group of cells constituting the main
source of HLJ1 reduction after UV irradiation, total,
detached and adherent cells were harvested and subjected
to ﬂow cytometry. The sub-G1 percentage of total cells
exposed to UV irradiation was up to 44.97%, while that
of detached cells was 61.69% (Figure 5B). In contrast, the
sub-G1 percentage of adherent cells was only 7.11%,
similar to control cells not exposed to UV. Annexin-V
staining disclosed similar results (data not shown).
Furthermore, in CL1-0 and HeLa cultures, the amount
of HLJ1 was obviously decreased in the total and
detached cell populations, particularly in the latter
almost completely depleted of HLJ1 (Figure 5C).
Compared with control cells, the HLJ1 protein level in
adherent cells was only slightly decreased after UV
exposure.
Figure 1. HLJ1 expression and UV-induced apoptosis in NSCLC cell
lines. (A) Expression of HLJ1 in diﬀerent NSCLC cell lines. HLJ1 was
detected by western blot analysis with b-tubulin as an internal control.
(B) Relative expression of HLJ1 was calculated by normalizing against
the corresponding densities of the internal control. (C) UV irradiation
induces cell apoptosis. NSCLC cell lines were exposed to 10J/m
2 of UV
and allowed to recover for 12h. Apoptotic cells were determined as the
sub-G1 percentage using ﬂow cytometry. CTL, no treatment control.
Data are presented as mean±SD of three experiments.
Nucleic Acids Research, 2010,Vol.38, No. 18 6151In this model of UV-induced degradation of HLJ1, we
further investigated the eﬀects of the pan-caspase inhibi-
tor, zVAD-fmk and the caspase-3-speciﬁc inhibitor,
DEVD-fmk, on UV-induced apoptosis. CL1-0 cells were
pre-treated with the inhibitors and subjected to UV treat-
ment. Both zVAD-fmk and DEVD-fmk signiﬁcantly in-
hibited UV-induced cell apoptosis in ﬂow cytometry
analysis (a=0.05, P=0.0002 and P=0.001, respect-
ively) (Figure 5D). Moreover, western blot analysis
revealed that zVAD-fmk and DEVD-fmk blocked the
degradation of HLJ1 as well as the caspase-3 substrate,
PARP (Figure 5E). Based on the data, we propose that
HLJ1 is cleaved by caspases, in particular, caspase-3,
during apoptosis induced by UV irradiation.
HLJ1 is a novel substrate of caspase-3 cleaved at Asp128
The lung cancer cell line, CL1-5, was transiently trans-
fected with V5-tagged HLJ1, irradiated with 50J/m
2 of
UV, and allowed to recover for 24h. A distinct band
was observed at  31kDa (Figure 6A). To determine the
speciﬁc cleavage site of caspase-3 in HLJ1, bacterially ex-
pressed His-tagged HLJ1 was puriﬁed and treated with
various amounts of active recombinant caspase-3. HLJ1
was cleaved by caspase-3 in an enzyme concentration-
dependent manner to produce two fragments with molecu-
lar weights of about 24 and 15kDa, respectively
(Figure 6B). The addition of DEVD-fmk to the reaction
prevented the degradation of HLJ1. The two bands were
conﬁrmed by MALDI-TOF mass spectrometry.
Furthermore, N-terminal amino acid sequencing of





(Figure 6C). To conﬁrm the cleavage site, an in vitro
cleavage assay was performed using the mutant HLJ1
(D128A) and inactive caspase-3 (C163S). In contrast to
wild-type HLJ1, HLJ1-D128A was not cleaved into the
24 and 15kDa products by active caspase-3.
Additionally, HLJ1 was not cleaved by an inactive form
of caspase-3. BSA was employed as a negative control
(Figure 6D).
Cleavage of HLJ1 is required for apoptosis
To determine the relationship between HLJ1 cleavage and
UV-induced apoptosis, V5-tagged HLJ1 and mutant
HLJ1 (D128A) stable transfectants were exposed to UV
irradiation, followed by ﬂow cytometry. The results
showed that the sub-G1 percentage of V5-tagged
HLJ1-transfected cells was signiﬁcantly increased, as
compared with mock cells (a=0.05, P=0.0001)
(Figure 7A). Interestingly, mutant HLJ1-transfected cells
showed a marked decrease of apoptosis, compared to
HLJ1 transfectants (a=0.05, P=0.0001). We further
Figure 2. UV-induced apoptosis in HLJ1-expressing CL1-5 cells. (A) HLJ1 induces morphological changes in lung cancer cells. Cells were plated in
dishes for 24h, and photographed using a microscope (optical magniﬁcation:  200). (B) Generation of lung cancer cell lines constitutively express-
ing HLJ1. The HLJ1 protein level was determined by western blot analysis. Levels of ectopically expressed HLJ1 in HLJ1-1 and HLJ1-2 cell lines
were higher than those of endogenous HLJ1 in the CL1-5 cell lines, mock-1 and mock-2. (C) HLJ1 augments cell apoptosis induced by UV
irradiation. CL1-5, mock and HLJ1 transfectants were exposed to 50J/m
2 of UV irradiation, and allowed to recover for the indicated times (6,
12 and 48h). The percentages of apoptotic cells were quantiﬁed by ﬂow cytometry, and presented as mean±S.D. of three experiments. (D)
Reduction of HLJ1 diminishes cell apoptosis induced by UV exposure. L, scrambled control; A, HLJ1 silence. The percentages of apoptotic cells
are presented as mean±S.D. of three experiments.
6152 Nucleic Acids Research, 2010,Vol.38, No. 18examined the phosphorylation of JNK and the activity of
caspase in mutant HLJ1 transfectant exposed to UV
stress. Mutant HLJ1 (D128A) inhibited JNK activation
by reducing phosphorylation of JNK but had no eﬀect
on JNK protein level (Figure 7B). Enforced expression
of HLJ1 increased the activation of caspase-9 and
the cleavage form of PARP in UV-exposed cells,
while mutant HLJ1 recovered the phenomenon
(Figure 7C). Moreover, HLJ1 mutation blocked the
reduction of HLJ1 caused by UV stress. All of these
indicators showed that HLJ1 is cleaved at Asp128
in vivo and HLJ1 cleavage is required for UV-induced
apoptosis.
Reduction of HLJ1 is appeared in other
stress-induced apoptosis
To investigate the eﬀect of HLJ1 on other stress-induced
apoptosis, ionizing irradiation and drugs were employed
to treat CL1-0, CL1-5 and stable HLJ1-transfected cells.
The results are illustrated in the Supplementary Material.
The sub-G1 percentage of cells was measured after 10, 15
or 20Gy X-irradiation and recovery for 72h. Just like
UV-induced apoptosis, the apoptotic cell percentage
caused by X-irradiation in CL1-0 was increased more
markedly than in CL1-5 (P=0.079 at 10Gy; P=0.014
at 15Gy; P=0.003 at 20Gy) (Supplementary Figure
S1A, left). And HLJ1 overexpression in CL1-5 cells
would enhance the sub-G1 percentage as compared with
mock at the indicated irradiation doses, from 22.39%,
46.65% and 56.02% to 30.25%, 52.70% and 67.37%, re-
spectively (Supplementary Figure S1A, right). However,
Figure 4. HLJ1 reduction by UV irradiation. (A) HLJ1 is decreased following UV exposure in a dose-dependent manner. CL1-0 cells were
irradiated with 10, 20 or 50J/m
2 of UV, and allowed to recover for 6h. Expression of HLJ1, Hsc70 and Hsp70 was detected by western blot
analysis. (B) HLJ1 is decreased after UV exposure in a time-dependent manner. CL1-0 cells were irradiated with 10J/m
2 of UV, and allowed to
recover for 3, 6, 9, 12 or 24h. Cell extracts were analyzed by western blot with anti-HLJ1, anti-Hsc70, anti-PARP and anti-caspase-3 antibodies. (C)
Ectopically expressed HLJ1 is decreased after UV exposure. Mock- and HLJ1-transfected cells derived from CL1-5 were exposed to 50J/m
2 of UV
irradiation, followed by recovery for 12h. HLJ1 was detected by western blot analysis using an anti-HLJ1 antibody. b-tubulin was used as the
internal control.
Figure 3. Eﬀect of HLJ1 on activation of JNK and caspase-3 after UV
irradiation. (A) Ectopic expression of HLJ1 enhances JNK activity
after UV irradiation. Mock (mock-1 and mock-2) and HLJ1 transfect-
ants (HLJ1-1 and HLJ1-2) were irradiated with 50J/m
2 of UV,
followed by recovery for 15 or 60min. Activated and total JNKs
were detected by western blotting with antibodies speciﬁc for JNK
and p-JNK, respectively. (B) Enforced expression of HLJ1 enhances
caspase-3 and -9 activities. Mock and HLJ1 transfectants were
exposed to 50J/m
2 of UV, and allowed to recover for 12 or 24h.
Cell extracts were analyzed for caspase-3, -9 and PARP by western
blotting with anti-caspase-3, anti-caspase-9 and anti-PARP antibodies.
b-tubulin was used as a control for protein loading.
Nucleic Acids Research, 2010,Vol.38, No. 18 6153the enforced expression of HLJ1 did not result in the
obvious sensitivity to the drugs used in this study (data
not shown). We next investigated if HLJ1 is also cleaved
in apoptotic cells caused by X-irradiation or drugs
including paclitaxel and staurosporine. Our results
demonstrated a dose-dependent decrease of HLJ1
protein in CL1-0 and CL1-5 exposed to X-irradiation
(Supplementary Figure S1B). The result also revealed
that HLJ1 could be cleaved to yield the cleaved form in
stable transfectant treated with X-ray irradiation,
paclitaxel or staurosporine, while mutant HLJ1 (D128A)
blocked the processing (Supplementary Figure S1C
and D). In addition, PARP was cleaved in parallel with
wild-type HLJ1; however, the cleavage was reduced with
mutant HLJ1 (D128A) in all assays, suggesting that the
cleavage of HLJ1 is required for caspase-3 activity.
Figure 5. Caspase-dependent HLJ1 reduction in apoptotic cells. (A) Decreased expression of HLJ1 was pronounced upon inhibition of protein
synthesis. CL1-0 cells were pre-incubated with 10mg/ml of CHX for an hour, and exposed to 10J/m
2 of UV. After recovery for 6h, HLJ1 expression
was analyzed by western blot using anti-HLJ1 antibody (left) and real-time RT–PCR (right). (B) The majority of detached cells induced by UV
irradiation were apoptotic. CL1-0 cells were irradiated with 10J/m
2 of UV, and allowed to recover for 24h. Based on adherence, total cells including
detached and adherent, adherent cells and detached cells, were harvested. The DNA content of cells was analyzed by ﬂow cytometry, as described in
‘Materials and Methods’ section. (C) HLJ1 was absent in detached cells. CL1-0 and HeLa cells were treated with 10J/m
2 of UV irradiation, and
allowed to recover for 24h. Total cells (T), adherent cells (A) and detached cells (D) were collected for western blot analysis with anti-HLJ1 and
anti-Hsc70 antibodies. b-Tubulin was applied as the internal control. Results are representative of three independent experiments. (D) Caspase
inhibitors attenuated UV-induced cell apoptosis. CL1-0 cells were pre-incubated for 3h with 20mM zVAD-fmk or 30mM DEVD-fmk, followed by
exposure to 10J/m
2 of UV irradiation. After recovery for 6h, the apoptotic cell content was determined based on the sub-G1 proportion using a ﬂow
cytometer. Data are presented as mean±S.D. (n=3). (E) Caspase inhibitors blocked UV-induced HLJ1 degradation. Western blots were performed
with antibodies against HLJ1, PARP or b-tubulin. PARP is a caspase-3 substrate, while b-tubulin is the internal control.
6154 Nucleic Acids Research, 2010,Vol.38, No. 18Figure 7. Eﬀect of HLJ1 cleavage on UV-induced apoptosis. (A)
HLJ1-D128A mutant is resistant to UV-induced apoptosis. After UV
irradiation, the sub-G1 percentages of vector-transfected control cells
(Mock), HLJ1-transfected cells (HLJ1) and mutant HLJ1-transfected
cells (D128A-mixed clone and D128A-single clone) were detected by
ﬂow cytometry. Data are presented as mean±S.D. of three independ-
ent experiments. (B) UV-induced JNK activation is defective in mutant
HLJ1 transfectant. Wild-type HLJ1 and mutant HLJ1 (D128A) trans-
fectants were irradiated by UV light followed by incubation at 37 C for
15 or 30min. JNK activity was detected by western blotting with an
anti-p-JNK antibody. a-Actinin served as the loading control. The ex-
pression of V5-tagged HLJ1 in transfectant was detected with an
anti-V5 tag antibody. (C) Rescue of the caspase pathway by expression
of HLJ1-D128A mutant protein. Mock, HLJ1 and mutant HLJ1 trans-
fectants were exposed to 50J/m
2 of UV, and recovered for 24 and 48h.
Cell extracts were analyzed for V5-tagged HLJ1, caspase-9 and PARP
by western blotting with the indicated antibodies. GAPDH was used as
a control for protein loading.
Figure 6. Caspase-3 cleavage site of HLJ1. (A) In vivo cleavage of
HLJ1 by exposure to UV stress. CL1-5 cells were transiently trans-
fected with V5-tagged HLJ1 and exposed to 50J/m
2 of UV irradiation.
After recovery for 24h, induced HLJ1 expression was detected by
western blot analysis with an anti-V5 tag antibody. (B) In vitro
cleavage of HLJ1 by recombinant caspase-3. The puriﬁed His-tagged
HLJ1 was incubated with a series of concentrations of active caspase-3
at 37 C for 2h, and subjected to SDS–PAGE followed by Coomassie
blue staining. (C) Illustration of caspase-3-mediated cleavage of HLJ1.
The cleaved 24kDa HLJ1 fragment was subjected to N-terminal amino
acid sequencing. The cleavage site is marked with an arrow at position
128 (Asp) in the G/F-rich domain. (D) Eﬀects of HLJ1-D128A and
caspase-3-C163S in an in vitro cleavage assay. Puriﬁed His-tagged
HLJ1 or HLJ1-D128A were incubated with active caspase-3 or
GST-caspase-3-C163S at 37 C for 2h, and analyzed using
SDS–PAGE, followed by Coomassie blue staining. BSA was
employed as a negative control.
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Evasion of apoptosis is a hallmark of most cancers. Thus,
it is important to identify genes that promote apoptosis in
cancer cells, either under normal or stress conditions, such
as radiotherapy and chemotherapy. Several recent studies
show that HSPs play important cytoprotective roles, and
are involved in regulation of the apoptosis pathway (24).
HLJ1, a member of the Hsp 40 family, is a newly identiﬁed
tumor suppressor closely related to tumorigenesis as well
as a predictor of relapse and survival in NSCLC patients
(17). However, the role of HLJ1 in apoptosis is currently
unknown. In this study, we demonstrate that HLJ1
promotes UV-induced apoptosis through enhancing
JNK and caspase-3 activation in NSCLC. Moreover,
HLJ1 is a novel target of caspase-3 that is degraded at
the late stage of apoptosis. A non-typical caspase-3
cleavage site (MEID) located at positions 125–128 of
HLJ1 has been identiﬁed.
While it is implied that HSPs regulate apoptosis, diverse
results have been obtained to date. For instance, Hsp27
prevents cell death from gamma irradiation in Jurkat–
Hsp27 cells (25) and inhibits Bax-mediated apoptosis via
a PI3K-dependent pathway in renal epithelial cells (26).
Hsp70 acts against apoptosis induced by a variety of stress
conditions through suppression of JNK activation, pre-
venting recruitment of procaspase-9 to the Apaf-1
apoptosome and inhibiting caspase-3 activation (27). In
contrast, Hsp60 and Hsp90 play both anti- and
pro-apoptotic roles. Release of mitochondrial Hsp60/
Hsp10 stimulates the activation of caspase-3 in HeLa
and Jurkat cells, and Hsp90 promotes the rate of
TNF-induced apoptosis (10,28). Other studies show that
overexpression of Hsp60 enhances the survival rate in
cardiac myocytes during ischemia injury (29), and Hsp90
directly binds Apaf-1 to inhibit the activation of caspase-9
(30). On the other hand, oxidative stress-induced apop-
tosis was enhanced by Hsp105a in mouse embryonic F9
cell lines, but reduced in neuronal PC12 cells (11,12). To
our knowledge, this is the ﬁrst report to show that HLJ1, a
Hsp40 protein, acts as an enhancer of apoptosis by
increasing JNK and caspase-3 activities in the NSCLC
cell line.
JNK, also designated stress-induced kinase, is part of a
family of mitogen-activated protein (MAP) kinases,
including ERK and p38 kinase (4). Stimulation of the
JNK signaling pathway induced by external stress
factors, such as UV irradiation, leads to apoptosis (4).
The JNK pathway is involved in activation of caspases
and initiation of the apoptotic process in a variety of
cell types (31,32). Our results indicate that the increase
in JNK activity is more marked in HLJ1-overexpressing
than mock control cells (Figure 3A). Thus, HLJ1 may
promote UV stress-induced apoptosis through enhancing
JNK activation in a CL1-5 cell line. The apoptosis
pathway involves activation of caspases, which are
stimulated in a proteolytic cascade to cleave speciﬁc sub-
strates, such as PARP (33). Caspase activation is initiated
through two major apoptotic mechanisms, speciﬁcally, the
mitochondrial death and receptor-mediated cell death
pathways. The mitochondrial death pathway follows the
release of cytochrome c from mitochondria and activates
caspase-9, which, in turn, activates downstream eﬀector
caspases, such as caspase-3 (34). A previous report add-
itionally showed that JNK promotes caspase activation
through cytochrome c release and apoptosome activation
induced by UV stress (35). Here, we demonstrate that
enforced expression of HLJ1 enhances PARP cleavage
and caspase-3 activity in CL1-5 cells irradiated with UV,
ultimately leading to increased apoptosis.
In general, HSPs display basal expression levels in
non-stressed cells. Earlier studies indicate that expression
levels of these proteins are strongly elevated under stress
conditions (36). In contrast, our data show that the
amount of HLJ1 is reduced in UV-exposed cells, and
almost completely depleted by the late apoptotic stage.
During apoptotic progression, caspases cleave speciﬁc
substrates and mediate biochemical and morphological
changes, such as cell shrinkage and membrane blebbing
(37). Recently, several classes of substrates that are
cleaved by caspases during apoptosis have been identiﬁed,
including proteins involved in DNA metabolism and
repair, signal transduction pathways, and regulation of
cell cycle and proliferation, as well as those playing a
direct role in apoptosis following cleavage (38). An
article published in 1998 indicates that Hsp90 is a candi-
date substrate of apoptosis-associated proteolysis (39).
However, there is no direct evidence conﬁrming that
HSPs are substrates of caspases. Surprisingly, data from
our UV irradiation-induced apoptotic model conﬁrm that
HLJ1 is a substrate of caspase-3, and its reduction is
attributed to cleavage at position 128 (aspartic acid).
Caspase-3 usually cleaves substrates with a consensus
motif of DXXD (P4–P3–P2–P1) (38) and the P1
position has absolute selectivity for Asp. Nevertheless,
several caspase-3 substrates, such as STAT1 (40) and
HAX (21) lack a typical DXXD motif. Additionally, a
recent review reported a preference for glycine, alanine,
threonine, serine and asparagine in P10, and the invariant
preference of the P3 position is glutamic acid for all mam-
malian caspases (41,42). While the caspase-3 cleavage
motif, MEID, in the HLJ1 protein is non-typical, the
amino acids at positions P1 and P3 are consistent with
the above ﬁndings. However, this novel motif in HLJ1 is
unique, and distinct to previously identiﬁed cleavage sites.
In addition to UV stress, the other stresses that can
induce apoptosis to cancer cells by various mechanisms,
such as X-irradiation, paclitaxel and staurosporine, are
included in this study to investigate the role of HLJ1 in
apoptosis and the cleavage of HLJ1 caused by caspase-3.
X-irradiation, an ionizing radiation, induces both single-
and double-strand breaks and causes a lethal eﬀect.
Paclitaxel, a mitotic inhibitor, interferes with the break-
down of microtubules during cell division and induces cell
arrest in the G2/M phase. Staurosporine is a potent inhibi-
tor of phospholipid/Ca
2+-dependent protein kinase
(protein kinase C; PKC) and widely employed as an
inducer of apoptosis in many mammalian cell types (43).
We found that overexpression of HLJ1 in CL1-5 cells also
enhances X-irradiation-induced apoptosis, such as
UV-induced apoptosis. These data indicate that HLJ1 is
associated with radiosensitivity. The cleaved HLJ1 was
6156 Nucleic Acids Research, 2010,Vol.38, No. 18also observed when CL1-0, CL1-5 and HLJ1-transfected
cells were treated with X-irradiation or drugs, but not
observed in mutant HLJ1-transfected cells. Moreover,
our results showed that overexpression of HLJ1
enhances PARP cleavage caused by caspase-3 activity in
CL1-5 exposed to UV-irradiation, X-irradiation or drugs,
even though HLJ1 overexpression has no apparent eﬀect
on drug-induced apoptosis. In particular, the expression
of mutant HLJ1 (D128A) decreased the cleavage of PARP
in all assays. Taken together, these results implied that
HLJ1 could enhance the apoptosis at or upstream of
caspase-3 activation and the cleavage of HLJ1 might
also enhance the activation of caspase-3.
HLJ1, also designated DNAJB4, contains three distinct
domains (13) (Figure 6C): (i) the J domain (amino acids
1-67) near the N-terminus that mediates interactions with
Hsp70 and regulates ATPase activity of Hsp70; (ii) a
glycine and phenylalanine (G/F)-rich region (positions
68–141) that is disordered and possibly acts as a ﬂexible
linker; and (iii) the C-terminal domain (positions 200–321)
forming a b-sheet structure involved in substrate binding
and presentation. A recently published prediction model
of HLJ1–Hsp70 interactions implies that HLJ1 binds the
ATPase domain of Hsp70 through its J domain and the C
termini of both HSPs interact together (13). Our results
indicate that HLJ1 is cleaved by caspase-3 at D
128 of
MEID
128G, which is located at the terminus of the
G/F-rich region possibly responsible for ﬂexibility.
Therefore, it is reasonable to speculate that
caspase-cleaved HLJ1 loses the ability to interact with
both the ATPase and substrate-binding domains of
Hsp70, leading to loss of function, despite no decrease
in the Hsp70 level during apoptosis.
In conclusion, HLJ1 promotes the sensitivity of cancer
cells to UV stress-induced apoptosis through enhancing
JNK activation and caspase activity. Moreover, the
HLJ1 protein is cleaved by caspase-3, followed by
protein degradation during the apoptotic process. HLJ1
appears to play an important role in apoptosis. However,
further studies are necessary to determine the underlying
mechanism of HLJ1 in UV-induced apoptosis and the
eﬀects of HLJ1 reduction during the late apoptotic
process. A therapeutic strategy based on induced expres-
sion of HLJ1 may be developed in the future, with a view
to synergistically elevate the eﬀects of radiotherapy and
prolonge patient survival.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Funding for open access charge: Taichung Veterans
General Hospital and National Chung Hsing University,
Taichung, Taiwan, R.O.C. (TCVGH-NCHU-957608);
Ministry of Education, Taiwan, R.O.C. under the ATU
plan (in part); National Science Council, Taiwan, R.O.C.
(NSC 98-2314-B-005-001-MY3).
Conﬂict of interest statement. None declared.
REFERENCES
1. Zhang,J., Cado,D., Chen,A., Kabra,N.H. and Winoto,A. (1998)
Fas-mediated apoptosis and activation-induced T-cell proliferation
are defective in mice lacking FADD/Mort1. Nature, 392, 296–300.
2. Chang,G.C., Hsu,S.L., Tsai,J.R., Liang,F.P., Lin,S.Y., Sheu,G.T.
and Chen,C.Y. (2004) Molecular mechanisms of ZD1839-induced
G1-cell cycle arrest and apoptosis in human lung adenocarcinoma
A549 cells. Biochem. Pharmacol., 68, 1453–1464.
3. Verbrugge,I., de Vries,E., Tait,S.W., Wissink,E.H., Walczak,H.,
Verheij,M. and Borst,J. (2008) Ionizing radiation modulates the
TRAIL death-inducing signaling complex, allowing bypass of the
mitochondrial apoptosis pathway. Oncogene, 27, 574–584.
4. Roduit,R. and Schorderet,D.F. (2008) MAP kinase pathways in
UV-induced apoptosis of retinal pigment epithelium ARPE19
cells. Apoptosis, 13, 343–353.
5. Wang,L.E., Li,C., Strom,S.S., Goldberg,L.H., Brewster,A.,
Guo,Z., Qiao,Y., Clayman,G.L., Lee,J.J., El-Naggar,A.K. et al.
(2007) Repair capacity for UV light induced DNA damage
associated with risk of nonmelanoma skin cancer and tumor
progression. Clin. Cancer Res., 13, 6532–6539.
6. Ritossa,F. (1962) A new puﬃng pattern induced by heat shock
and DNP in Drosophila. Experientia, 18, 571–573.
7. Qian,S.B., McDonough,H., Boellmann,F., Cyr,D.M. and
Patterson,C. (2006) CHIP-mediated stress recovery by sequential
ubiquitination of substrates and Hsp70. Nature, 440, 551–555.
8. Jaattela,M., Wissing,D., Kokholm,K., Kallunki,T. and
Egeblad,M. (1998) Hsp70 exerts its anti-apoptotic function
downstream of caspase-3-like proteases. EMBO J., 17, 6124–6134.
9. Pandey,P., Farber,R., Nakazawa,A., Kumar,S., Bharti,A.,
Nalin,C., Weichselbaum,R., Kufe,D. and Kharbanda,S. (2000)
Hsp27 functions as a negative regulator of cytochrome
c-dependent activation of procaspase-3. Oncogene, 19, 1975–1981.
10. Samali,A., Cai,J., Zhivotovsky,B., Jones,D.P. and Orrenius,S.
(1999) Presence of a pre-apoptotic complex of pro-caspase-3,
Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells.
EMBO J., 18, 2040–2048.
11. Hatayama,T., Yamagishi,N., Minobe,E. and Sakai,K. (2001) Role
of Hsp105 in protection against stress-induced apoptosis in
neuronal PC12 cells. Biochem. Biophys. Res. Commun., 288,
528–534.
12. Yamagishi,N., Saito,Y., Ishihara,K. and Hatayama,T. (2002)
Enhancement of oxidative stress-induced apoptosis by
Hsp105alpha in mouse embryonal F9 cells. Eur. J. Biochem., 269,
4143–4151.
13. Borges,J.C., Fischer,H., Craievich,A.F. and Ramos,C.H. (2005)
Low resolution structural study of two human HSP40 chaperones
in solution. DJA1 from subfamily A and DJB4 from subfamily B
have diﬀerent quaternary structures. J. Biol. Chem., 280,
13671–13681.
14. Gotoh,T., Terada,K., Oyadomari,S. and Mori,M. (2004)
Hsp70-DnaJ chaperone pair prevents nitric oxide- and
CHOP-induced apoptosis by inhibiting translocation of Bax to
mitochondria. Cell Death Diﬀer., 11, 390–402.
15. Mitra,A., Fillmore,R.A., Metge,B.J., Rajesh,M., Xi,Y., King,J.,
Ju,J., Pannell,L., Shevde,L.A. and Samant,R.S. (2008) Large
isoform of MRJ (DNAJB6) reduces malignant activity of breast
cancer. Breast Cancer Res., 10, R22.
16. Hoe,K.L., Won,M., Chung,K.S., Jang,Y.J., Lee,S.B., Kim,D.U.,
Lee,J.W., Yun,J.H. and Yoo,H.S. (1998) Isolation of a new
member of DnaJ-like heat shock protein 40 (Hsp40) from human
liver. Biochim. Biophys. Acta, 1383, 4–8.
17. Tsai,M.F., Wang,C.C., Chang,G.C., Chen,C.Y., Chen,H.Y.,
Cheng,C.L., Yang,Y.P., Wu,C.Y., Shih,F.Y., Liu,C.C. et al.
(2006) A new tumor suppressor DnaJ-like heat shock protein,
HLJ1, and survival of patients with non-small-cell lung
carcinoma. J. Natl Cancer Inst., 98, 825–838.
18. Wang,C.C., Tsai,M.F., Hong,T.M., Chang,G.C., Chen,C.Y.,
Yang,W.M., Chen,J.J. and Yang,P.C. (2005) The transcriptional
factor YY1 upregulates the novel invasion suppressor HLJ1
expression and inhibits cancer cell invasion. Oncogene, 24,
4081–4093.
19. Wang,C.C., Tsai,M.F., Dai,T.H., Hong,T.M., Chan,W.K.,
Chen,J.J. and Yang,P.C. (2007) Synergistic activation of the
Nucleic Acids Research, 2010,Vol.38, No. 18 6157tumor suppressor, HLJ1, by the transcription factors YY1 and
activator protein 1. Cancer Res., 67, 4816–4826.
20. Chen,J.J., Peck,K., Hong,T.M., Yang,S.C., Sher,Y.P., Shih,J.Y.,
Wu,R., Cheng,J.L., Roﬄer,S.R., Wu,C.W. et al. (2001) Global
analysis of gene expression in invasion by a lung cancer model.
Cancer Res., 61, 5223–5230.
21. Lee,A.Y., Lee,Y., Park,Y.K., Bae,K.H., Cho,S., Lee do,H.,
Park,B.C., Kang,S. and Park,S.G. (2008) HS 1-associated protein
X-1 is cleaved by caspase-3 during apoptosis. Mol. Cells, 25,
86–90.
22. Bromley,R., Oliver,L., Davey,R., Harvie,R. and Baldock,C. (2009)
Predicting the clonogenic survival of A549 cells after modulated
x-ray irradiation using the linear quadratic model. Phys. Med.
Biol., 54, 187–206.
23. Kim,M.A., Kim,H.J., Jee,H.J., Kim,A.J., Bae,Y.S., Bae,S.S. and
Yun,J. (2009) Akt2, but not Akt1, is required for cell survival by
inhibiting activation of JNK and p38 after UV irradiation.
Oncogene, 28, 1241–1247.
24. Sreedhar,A.S. and Csermely,P. (2004) Heat shock proteins in the
regulation of apoptosis: new strategies in tumor therapy: a
comprehensive review. Pharmacol. Ther., 101, 227–257.
25. Aloy,M.T., Hadchity,E., Bionda,C., Diaz-Latoud,C., Claude,L.,
Rousson,R., Arrigo,A.P. and Rodriguez-Lafrasse,C. (2008)
Protective role of Hsp27 protein against gamma radiation-induced
apoptosis and radiosensitization eﬀects of Hsp27 gene silencing in
diﬀerent human tumor cells. Int. J. Radiat. Oncol. Biol. Phys., 70,
543–553.
26. Havasi,A., Li,Z., Wang,Z., Martin,J.L., Botla,V., Ruchalski,K.,
Schwartz,J.H. and Borkan,S.C. (2008) Hsp27 inhibits Bax
activation and apoptosis via a phosphatidylinositol
3-kinase-dependent mechanism. J. Biol. Chem., 283, 12305–12313.
27. Kim,H.E., Jiang,X., Du,F. and Wang,X. (2008) PHAPI, CAS,
and Hsp70 promote apoptosome formation by preventing Apaf-1
aggregation and enhancing nucleotide exchange on Apaf-1.
Mol. Cell, 30, 239–247.
28. Galea-Lauri,J., Richardson,A.J., Latchman,D.S. and Katz,D.R.
(1996) Increased heat shock protein 90 (Hsp90) expression leads
to increased apoptosis in the monoblastoid cell line U937
following induction with TNF-alpha and cycloheximide: a
possible role in immunopathology. J. Immunol., 157, 4109–4118.
29. Hollander,J.M., Lin,K.M., Scott,B.T. and Dillmann,W.H. (2003)
Overexpression of PHGPx and HSP60/10 protects against
ischemia/reoxygenation injury. Free Radic. Biol. Med., 35,
742–751.
30. Pandey,P., Saleh,A., Nakazawa,A., Kumar,S., Srinivasula,S.M.,
Kumar,V., Weichselbaum,R., Nalin,C., Alnemri,E.S., Kufe,D.
et al. (2000) Negative regulation of cytochrome c-mediated
oligomerization of Apaf-1 and activation of procaspase-9 by heat
shock protein 90. EMBO J., 19, 4310–4322.
31. Lorenzo,P.I. and Saatcioglu,F. (2008) Inhibition of apoptosis in
prostate cancer cells by androgens is mediated through
downregulation of c-Jun N-terminal kinase activation. Neoplasia,
10, 418–428.
32. Zhang,J.Y., Jiang,H., Gao,W., Wu,J., Peng,K., Shi,Y.F. and
Zhang,X.J. (2008) The JNK/AP1/ATF2 pathway is involved in
H2O2-induced acetylcholinesterase expression during apoptosis.
Cell. Mol. Life Sci., 65, 1435–1445.
33. Tewari,M., Quan,L.T., O’Rourke,K., Desnoyers,S., Zeng,Z.,
Beidler,D.R., Poirier,G.G., Salvesen,G.S. and Dixit,V.M. (1995)
Yama/CPP32 beta, a mammalian homolog of CED-3, is a
CrmA-inhibitable protease that cleaves the death substrate
poly(ADP-ribose) polymerase. Cell, 81, 801–809.
34. Li,P., Nijhawan,D., Budihardjo,I., Srinivasula,S.M., Ahmad,M.,
Alnemri,E.S. and Wang,X. (1997) Cytochrome c and
dATP-dependent formation of Apaf-1/caspase-9 complex initiates
an apoptotic protease cascade. Cell, 91, 479–489.
35. Tournier,C., Hess,P., Yang,D.D., Xu,J., Turner,T.K., Nimnual,A.,
Bar-Sagi,D., Jones,S.N., Flavell,R.A. and Davis,R.J. (2000)
Requirement of JNK for stress-induced activation of the
cytochrome c-mediated death pathway. Science, 288, 870–874.
36. Chung,J., Nguyen,A.K., Henstridge,D.C., Holmes,A.G.,
Chan,M.H., Mesa,J.L., Lancaster,G.I., Southgate,R.J.,
Bruce,C.R., Duﬀy,S.J. et al. (2008) HSP72 protects against
obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA,
105, 1739–1744.
37. Wyllie,A.H., Kerr,J.F. and Currie,A.R. (1980) Cell death: the
signiﬁcance of apoptosis. Int. Rev. Cytol., 68, 251–306.
38. Earnshaw,W.C., Martins,L.M. and Kaufmann,S.H. (1999)
Mammalian caspases: structure, activation, substrates,
and functions during apoptosis. Annu. Rev. Biochem., 68,
383–424.
39. Prasad,S., Soldatenkov,V.A., Srinivasarao,G. and Dritschilo,A.
(1998) Identiﬁcation of keratins 18, 19 and heat-shock protein 90
beta as candidate substrates of proteolysis during ionizing
radiation-induced apoptosis of estrogen-receptor negative breast
tumor cells. Int. J. Oncol., 13, 757–764.
40. King,P. and Goodbourn,S. (1998) STAT1 is inactivated by a
caspase. J. Biol. Chem., 273, 8699–8704.
41. Thornberry,N.A., Rano,T.A., Peterson,E.P., Rasper,D.M.,
Timkey,T., Garcia-Calvo,M., Houtzager,V.M., Nordstrom,P.A.,
Roy,S., Vaillancourt,J.P. et al. (1997) A combinatorial approach
deﬁnes speciﬁcities of members of the caspase family and
granzyme B. Functional relationships established for key
mediators of apoptosis. J. Biol. Chem., 272, 17907–17911.
42. Timmer,J.C. and Salvesen,G.S. (2007) Caspase substrates.
Cell Death Diﬀer., 14, 66–72.
43. Svensson,R.U., Barnes,J.M., Rokhlin,O.W., Cohen,M.B. and
Henry,M.D. (2007) Chemotherapeutic agents up-regulate the
cytomegalovirus promoter: implications for bioluminescence
imaging of tumor response to therapy. Cancer Res., 67,
10445–10454.
6158 Nucleic Acids Research, 2010,Vol.38, No. 18